CD4+ T cells spontaneously producing human immunodeficiency virus type I in breast milk from women with or without antiretroviral drugs

Retrovirology. 2011 May 13:8:34. doi: 10.1186/1742-4690-8-34.

Abstract

Background: Transmission of human immunodeficiency virus type 1 (HIV-1) through breast-feeding may involve both cell-free and cell-associated virus. This latter viral reservoir remains, however, to be fully explored. CD4+ T cell-associated virus production in breast milk was therefore investigated.

Methods: The ex vivo spontaneous production of HIV-1 antigen and HIV-1 RNA by CD4+ T cells was measured in paired blood and breast milk samples from 15 HIV-1 infected women treated or not with antiretroviral drugs. Spontaneous antigen secreting cells (HIV-1-AgSCs) from breast milk and blood were enumerated by an ELISpot assay, and cell-associated HIV-1 RNA was quantified by real-time PCR in supernatants of CD4+ T cells cultured for 18 hours without addition of polyclonal activators.

Results: Among the CD4+ T cells present in breast milk, memory cells expressing high levels of cell-surface activation markers were predominant. Spontaneous HIV-1-AgSCs were detected and enumerated in the breast milk of all 15 women, with a median number of 13.0 and 9.5 HIV-1- AgSCs/106 CD4+ T cells in aviremic (n = 7) and viremic (n = 8) women, respectively. Cell- associated HIV-1 RNA was detected in cell-free supernatants from 4/7 aviremic and 5/8 viremic individuals at median levels of 190 and 245 copies/ml, respectively.

Conclusions: Activated CD4+ T cells producing HIV-1 are detected in the breast milk of untreated individuals as well as those receiving highly active antiretroviral therapy. This finding strongly suggests that HIV-1 replication occurs in latently infected CD4+ T cells that, upon spontaneous activation, revert to productively infected cells. These cells might be responsible for a residual breast milk transmission despite maternal highly active antiretroviral therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • CD4-Positive T-Lymphocytes / virology*
  • Enzyme-Linked Immunospot Assay
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / immunology
  • HIV Infections / transmission*
  • HIV Infections / virology*
  • HIV-1 / growth & development
  • HIV-1 / isolation & purification
  • HIV-1 / physiology*
  • Humans
  • In Vitro Techniques
  • Milk, Human / cytology*
  • Milk, Human / virology*
  • Pregnancy
  • RNA, Viral / biosynthesis
  • RNA, Viral / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Viral Proteins / biosynthesis
  • Viral Proteins / immunology
  • Virus Activation

Substances

  • Anti-HIV Agents
  • RNA, Viral
  • Viral Proteins